Calidi Biotherapeutics, Inc.

CLDI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
424B5 Nov 14, 2024
8-K Nov 13, 2024
10-Q Nov 12, 2024
25-NSE Oct 28, 2024
8-K Oct 24, 2024
424B5 Oct 24, 2024
424B5 Oct 23, 2024
8-K Oct 18, 2024
8-K Oct 18, 2024
4 Oct 15, 2024
4 Oct 15, 2024
4 Oct 15, 2024
4 Oct 15, 2024
424B5 Oct 11, 2024
8-K Oct 11, 2024
EFFECT Oct 10, 2024
CORRESP Oct 8, 2024
S-3/A Oct 7, 2024
UPLOAD Oct 7, 2024
S-3 Oct 1, 2024
S-8 Oct 1, 2024
4 Sep 30, 2024
8-K Sep 30, 2024
8-K Sep 24, 2024
8-K Sep 12, 2024
← Newer Page 6 of 17 · 403 filings Older →